DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-8.37%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.26B
AUM Growth
-$1.44B
(-21%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-22.76%
Top 10 Holdings %
Top 10 Hldgs %
53.77%
Holding
466
New
22
Increased
24
Reduced
24
Closed
360
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
+$87.7M |
| 2 |
Dynavax Technologies
DVAX
|
+$66M |
| 3 |
Oscar Health
OSCR
|
+$53.5M |
| 4 |
Legend Biotech
LEGN
|
+$50.5M |
| 5 |
Indivior
INDV
|
+$47.1M |
Top Sells
| 1 |
Nuvalent
NUVL
|
+$157M |
| 2 |
Kura Oncology
KURA
|
+$106M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$64.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$62.1M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$60.8M |
Sector Composition
| 1 | Healthcare | 88.36% |
| 2 | Industrials | 0.23% |
| 3 | Consumer Staples | 0.01% |
| 4 | Energy | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMAXW
201
DELISTED
CareMax, Inc. Warrant
CMAXW
| – | – |
-672,000
| Closed | -$6.65K |
|
|
CMAX
202
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| – | – |
-530,232
| Closed | -$901K |
|
203
Glaukos
GKOS
$5.21B
| – | – |
-1,938
| Closed | -$252K |
|
204
Globe Life
GL
$11.4B
| – | – |
-2,057
| Closed | -$218K |
|
205
Global Payments
GPN
$21.1B
| – | – |
-9,580
| Closed | -$981K |
|
206
Gorman-Rupp
GRC
$1.11B
| – | – |
-24,253
| Closed | -$945K |
|
207
Goldman Sachs
GS
$231B
| – | – |
-808
| Closed | -$400K |
|
208
Chart Industries
GTLS
$8.96B
| – | – |
-3,130
| Closed | -$389K |
|
209
Hackett Group
HCKT
$576M
| – | – |
-39,550
| Closed | -$1.04M |
|
210
Healthcare Services Group
HCSG
$1.17B
| – | – |
-66,786
| Closed | -$746K |
|
211
Helios Technologies
HLIO
$1.79B
| – | – |
-19,995
| Closed | -$954K |
|
212
Hallador Energy
HNRG
$748M
| – | – |
-112,711
| Closed | -$1.06M |
|
213
Hope Bancorp
HOPE
$1.41B
| – | – |
-25,959
| Closed | -$326K |
|
214
Hewlett Packard
HPE
$31.5B
| – | – |
-15,583
| Closed | -$319K |
|
215
HealthEquity
HQY
$8.01B
| – | – |
-11,781
| Closed | -$964K |
|
216
Harrow
HROW
$1.45B
| – | – |
-13,863
| Closed | -$623K |
|
217
Horizon Technology Finance
HRZN
$291M
| – | – |
-64,708
| Closed | -$689K |
|
218
HUB Group
HUBG
$2.23B
| – | – |
-15,555
| Closed | -$707K |
|
219
IAC Inc
IAC
$2.88B
| – | – |
-11,526
| Closed | -$509K |
|
220
Idexx Laboratories
IDXX
$52.4B
| – | – |
-2,643
| Closed | -$1.34M |
|
221
IDEX
IEX
$12.2B
| – | – |
-7,106
| Closed | -$1.52M |
|
222
Imperial Oil
IMO
$45.6B
| – | – |
-4,027
| Closed | -$284K |
|
223
Ingredion
INGR
$8.16B
| – | – |
-2,598
| Closed | -$357K |
|
224
Inovio Pharmaceuticals
INO
$146M
| – | – |
-76,523
| Closed | -$442K |
|
225
Insmed
INSM
$31.1B
| – | – |
-52,861
| Closed | -$3.86M |
|